ARF-BP1 can act to promote BL tumor development by: (1) inducing ubiquitylation and degradation of p53; (2) enhancing the transcriptional activity of MYC; and (3) by direct ubiquitylation of CTCF. Here, CTCF is linked to neoplasm.